Royals infielder Miguel Tejada, suspended last Saturday for 105 games for repeated use of amphetamines, was cleared Wednesday by Major League Baseball of any violation in regard to its Biogenesis investigation.
“The office of the commissioner investigated all allegations regarding players associated with Anthony Bosch and Biogenesis,” Major League Baseball said in a news release.
“The investigation found no violation by Miguel Tejada of the Joint Drug Prevention and Treatment Program.”
The action does not affect Tejada’s suspension, which resulted from failing two recent drug tests because of his use of Adderall, a substance generally used to treat narcolepsy and attention deficit hyperactivity disorder.
Biogenesis was a Florida clinic operated by Bosch and accused of providing banned substances to players.
The suspension took effect immediately Saturday when Tejada, 39, declined his right to appeal. It spans the rest of this season and the first 64 games of 2014.
Tejada issued an apology shortly after the suspension was announced.
“I apologize to my teammates, the Royals’ organization and to the Kansas City fans,” he said in a news release issued through the players’ union. “I have a medical condition that requires medication to treat.
“I took that medication while reapplying for a therapeutic use exemption. Under the requirements of the Joint Drug Program, I made a mistake in doing so.”
The suspension came six days after the Royals had placed Tejada on the 60-day disabled list because of a severely strained right calf suffered Aug. 10 while diving for a ground ball.